138 related articles for article (PubMed ID: 7814830)
1. The effect of fluoxetine on sleep: a longitudinal, double-blind polysomnographic study of healthy volunteers.
Vasar V; Appelberg B; Rimón R; Selvaratnam J
Int Clin Psychopharmacol; 1994 Sep; 9(3):203-6. PubMed ID: 7814830
[TBL] [Abstract][Full Text] [Related]
2. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities.
Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; See WR
Sleep; 1991 Oct; 14(5):439-47. PubMed ID: 1836894
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and mood.
Wilson SJ; Bailey JE; Alford C; Weinstein A; Nutt DJ
J Psychopharmacol; 2002 Dec; 16(4):321-31. PubMed ID: 12503831
[TBL] [Abstract][Full Text] [Related]
4. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
5. Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.
Cohrs S; Meier A; Neumann AC; Jordan W; Rüther E; Rodenbeck A
J Clin Psychiatry; 2005 Aug; 66(8):989-96. PubMed ID: 16086613
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects.
Feige B; Voderholzer U; Riemann D; Dittmann R; Hohagen F; Berger M
Neuropsychopharmacology; 2002 Feb; 26(2):246-58. PubMed ID: 11790520
[TBL] [Abstract][Full Text] [Related]
7. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
8. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder.
Schenck CH; Mahowald MW; Kim SW; O'Connor KA; Hurwitz TD
Sleep; 1992 Jun; 15(3):226-35. PubMed ID: 1621023
[TBL] [Abstract][Full Text] [Related]
9. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
Rush AJ; Armitage R; Gillin JC; Yonkers KA; Winokur A; Moldofsky H; Vogel GW; Kaplita SB; Fleming JB; Montplaisir J; Erman MK; Albala BJ; McQuade RD
Biol Psychiatry; 1998 Jul; 44(1):3-14. PubMed ID: 9646878
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
12. Effect of tetrahydroaminoacridine on sleep in healthy subjects.
Riemann D; Lis S; Fritsch-Montero R; Meier T; Krieger S; Hohagen F; Berger M
Biol Psychiatry; 1996 May; 39(9):796-802. PubMed ID: 8731520
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent effects of transdermal nicotine on early morning awakening and rapid eye movement sleep time in nonsmoking normal volunteers.
Gillin JC; Lardon M; Ruiz C; Golshan S; Salin-Pascual R
J Clin Psychopharmacol; 1994 Aug; 14(4):264-7. PubMed ID: 7962682
[TBL] [Abstract][Full Text] [Related]
14. The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans.
Wilson SJ; Bailey JE; Rich AS; Nash J; Adrover M; Tournoux A; Nutt DJ
J Psychopharmacol; 2005 Nov; 19(6):609-13. PubMed ID: 16272182
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, double-blind comparison of the effects of nefazodone and fluoxetine on sleep architecture and quality of sleep in depressed outpatients.
Armitage R; Yonkers K; Cole D; Rush AJ
J Clin Psychopharmacol; 1997 Jun; 17(3):161-8. PubMed ID: 9169959
[TBL] [Abstract][Full Text] [Related]
16. Pilocarpine, an orally active muscarinic cholinergic agonist, induces REM sleep and reduces delta sleep in normal volunteers.
Berkowitz A; Sutton L; Janowsky DS; Gillin JC
Psychiatry Res; 1990 Aug; 33(2):113-9. PubMed ID: 2243887
[TBL] [Abstract][Full Text] [Related]
17. Clonidine effects on all-night human sleep: opposite action of low- and medium-dose clonidine on human NREM-REM sleep proportion.
Miyazaki S; Uchida S; Mukai J; Nishihara K
Psychiatry Clin Neurosci; 2004 Apr; 58(2):138-44. PubMed ID: 15009817
[TBL] [Abstract][Full Text] [Related]
18. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression.
Kluge M; Schüssler P; Steiger A
Eur Neuropsychopharmacol; 2007 Jul; 17(8):527-31. PubMed ID: 17337164
[TBL] [Abstract][Full Text] [Related]
19. Effects of olanzapine, risperidone and haloperidol on sleep after a single oral morning dose in healthy volunteers.
Giménez S; Clos S; Romero S; Grasa E; Morte A; Barbanoj MJ
Psychopharmacology (Berl); 2007 Mar; 190(4):507-16. PubMed ID: 17205319
[TBL] [Abstract][Full Text] [Related]
20. Alcohol effect on sleep electroencephalography by fast Fourier transformation.
Kobayashi T; Misaki K; Nakagawa H; Okuda K; Ota T; Kanda I; Isaki K; Kosino Y; Fukuda H
Psychiatry Clin Neurosci; 1998 Apr; 52(2):154-5. PubMed ID: 9628123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
